In Stock

Glyaid-MV1 Tablet

₹ 735.00

Incl. GST

Select Variant

Why Choose Deepali Lifesciences?

Your data is protected with 256-bit SSL encryption for a 100% safe checkout.

Formulated in state-of-the-art facilities under strict global quality and compliance standards.

Not satisfied? We offer a 7-day hassle-free replacement on all orders.

Eco-friendly, multi-layer packaging to ensure your product arrive fresh and intact.

Field	Details
Product Name	Glyaid-MV1 Tablet
Category	Diabetology
Sub-Category	Anti-Diabetic
Formulation / Composition	Glimepiride IP 1 mg + Metformin Hydrochloride IP 500 mg Tablet
Dosage Form	Tablet
Therapeutic Class	Oral Anti-Diabetic
Pharmacological Class	Sulfonylurea + Biguanide Combination
Description	Glyaid-MV1 Tablet is a combination oral anti-diabetic medication containing Glimepiride IP 1 mg and Metformin Hydrochloride IP 500 mg. Glimepiride stimulates insulin secretion from the pancreatic β-cells, while Metformin decreases hepatic glucose production and improves insulin sensitivity. Together, they help achieve effective control of fasting and postprandial blood glucose levels, making the combination suitable for the management of Type 2 Diabetes Mellitus when diet and exercise alone are insufficient.
Indication	Type 2 Diabetes Mellitus
Key Benefits	Helps control blood glucose levels, improves insulin sensitivity, reduces hepatic glucose production, enhances glycemic control, and supports long-term diabetes management.
Administration	To be taken orally as directed by the physician, preferably with meals to minimize gastrointestinal side effects.
Storage	Store in a cool, dry place below 30°C. Protect from moisture and direct sunlight.
Pack Type	Tablets for Oral Administration
Strength	Glimepiride IP 1 mg + Metformin Hydrochloride IP 500 mg per Tablet